Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q1

4521.TEDINET S100RKL3
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥18.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥18.2bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥3.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥4.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥3.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.3bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥3.5bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥4.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥167.2bnat 2023-06-30Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥165.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥29.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥137.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥137.9bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥56.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥66.992023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥76.912022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥3.0bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-06-30¥321m
—segment totalrevenue2023-04-01 → 2023-06-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.3bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-06-30¥295m
—segment totalrevenue2022-04-01 → 2022-06-30¥18.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥18.2bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 374
ItemContextValueUnit
Operating incomePrior1YTDDuration4056000000JPY
Net sales of finished goods and merchandiseCurrentYTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember17226000000JPY
Net sales of finished goods and merchandiseCurrentYTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember－JPY
Net sales of finished goods and merchandiseCurrentYTDDuration_ReportableSegmentsMember17226000000JPY
Net sales of finished goods and merchandiseCurrentYTDDuration_ReconcilingItemsMember－JPY
Net sales of finished goods and merchandiseCurrentYTDDuration17226000000JPY
RoyaltyCurrentYTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember318000000JPY
RoyaltyCurrentYTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember－JPY
RoyaltyCurrentYTDDuration_ReportableSegmentsMember318000000JPY
RoyaltyCurrentYTDDuration_ReconcilingItemsMember－JPY
RoyaltyCurrentYTDDuration318000000JPY
Other incomeCurrentYTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember－JPY
Other incomeCurrentYTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember605000000JPY
Other incomeCurrentYTDDuration_ReportableSegmentsMember605000000JPY
Other incomeCurrentYTDDuration_ReconcilingItemsMember－JPY
Other incomeCurrentYTDDuration605000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember17545000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember605000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember18150000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration18150000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember17545000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember605000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember18150000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration18150000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember2972000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember321000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember3293000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember－JPY
Operating incomeCurrentYTDDuration3293000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第104期第１四半期(自　2023年４月１日　至　2023年６月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)科研製薬株式会社
Company name in english cover pageFilingDateInstantKAKEN PHARMACEUTICAL CO., LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　堀　内　裕　之
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都文京区本駒込二丁目28番８号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(5977)5007(ダイヤルイン)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経理部長　　伊　東　誠　司
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都文京区本駒込二丁目28番８号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(5977)5007(ダイヤルイン)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経理部長　　伊　東　誠　司

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass